Phase 3 trial of Novavax investigational COVID-19 vaccine opens | National Institutes of Health (NIH)

Phase 3 trial of Novavax investigational COVID-19 vaccine opens | National Institutes of Health (NIH): NIH- and BARDA-funded trial will enroll up to 30,000 volunteers.